{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:40:11Z","timestamp":1778812811925,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Maple syrup urine disease (MSUD) is an inherited neurometabolic disorder caused by a deficiency of branched-chain \u03b1-keto acid dehydrogenase complex activity. There is an accumulation of neurotoxic branched-chain amino acids and their corresponding alpha-ketoacids. During acute metabolic decompensation, there is a high risk of mortality due to encephalopathy and cerebral edema, leading to cerebellar herniation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects and methods<\/jats:title>\n                    <jats:p>This study reviewed the clinical presentation, management, and outcome of adult patients with MSUD who were admitted to our hospital with encephalopathy and cerebral edema during the 8-year study period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seven patients were admitted with ten episodes of encephalopathy, and cerebral edema was present during nine episodes. One asymptomatic patient had an elective admission with cerebral edema. Five patients had a full recovery to baseline, while two patients died.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study describes the variable clinical presentation of cerebral edema in adult patients with MSUD. Early recognition and prompt treatment of encephalopathy is challenging, particularly in adult patients, as the multidisciplinary teams may not be familiar with this rare disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-04043-1","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:57:20Z","timestamp":1763549840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cerebral edema in maple syrup urine disease: spectrum of clinical presentation and treatment outcomes"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6868-9823","authenticated-orcid":false,"given":"Raashda A.","family":"Sulaiman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruqaiah","family":"Altassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randa","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moeenaldeen","family":"Alsayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aamir N.","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manal","family":"Nicolas-Jilwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Al-Owain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuhair","family":"Al-Hassnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"4043_CR1","first-page":"279","volume-title":"Inborn metabolic diseases: diagnosis and treatment","author":"M Schiff","year":"2016","unstructured":"Schiff M, de Baulny HO, Dionisi-Vici C. Branched-chain organic acidurias\/acidaemias. In: Saudubray JM, Baumgartner MR, Walter J, editors. Inborn metabolic diseases: diagnosis and treatment. 6th ed. Heidelberg: Springer-Verlag; 2016. p. 279\u201388.","edition":"6"},{"key":"4043_CR2","first-page":"106","volume":"15","author":"KA Chapman","year":"2018","unstructured":"Chapman KA, Gramer G, Viall S, et al. Incidence of maple syrup urine disease, propionic acidemia, and methylmalonic aciduria from newborn screening data. Mol Genet Metab Rep. 2018;15:106\u20139.","journal-title":"Mol Genet Metab Rep"},{"issue":"6","key":"4043_CR3","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/jpc.13469","volume":"53","author":"M Alfadhel","year":"2017","unstructured":"Alfadhel M, Al Othaim A, Al Saif S, et al. Expanded newborn screening program in Saudi Arabia: incidence of screened disorders. J Paediatr Child Health. 2017;53(6):585\u201391.","journal-title":"J Paediatr Child Health"},{"issue":"3","key":"4043_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ymgme.2020.01.006","volume":"129","author":"KA Strauss","year":"2020","unstructured":"Strauss KA, Carson VJ, Soltys K, et al. Branched-chain \u03b1-ketoacid dehydrogenase deficiency (maple syrup urine disease): treatment, biomarkers, and outcomes. Mol Genet Metab. 2020;129(3):193\u2013206.","journal-title":"Mol Genet Metab"},{"key":"4043_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ymgme.2009.12.007","volume":"99","author":"KA Strauss","year":"2010","unstructured":"Strauss KA, Wardley B, Robinson D, et al. Classical maple syrup urine disease and brain development: principles of management and formula design. Mol Genet Metab. 2010;99:333\u201345.","journal-title":"Mol Genet Metab"},{"key":"4043_CR6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/brain\/awp024","volume":"132","author":"WJ Zinnanti","year":"2009","unstructured":"Zinnanti WJ, Lazovic J, Griffin K, et al. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain. 2009;132:903\u201318.","journal-title":"Brain"},{"issue":"20","key":"4043_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207490","volume":"21","author":"J Xu","year":"2020","unstructured":"Xu J, Jakher Y, Ahrens-Nicklas RC. Brain branched-chain amino acids in Maple Syrup Urine Disease: implications for neurological disorders. Int J Mol Sci. 2020;21(20):7490.","journal-title":"Int J Mol Sci"},{"key":"4043_CR8","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1007\/s12035-015-9313-0","volume":"53","author":"L Rosa","year":"2016","unstructured":"Rosa L, Galant LS, Dall\u2019Igna DM, et al. Cerebral oedema, blood-brain barrier breakdown and the decrease in Na (+), K(+)-ATPase activity in the cerebral cortex and hippocampus are prevented by dexamethasone in an animal model of maple syrup urine disease. Mol Neurobiol. 2016;53:3714\u201323.","journal-title":"Mol Neurobiol"},{"key":"4043_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/TACG.S125962","volume":"10","author":"PR Blackburn","year":"2017","unstructured":"Blackburn PR, Gass JM, Vairo FPE, et al. Maple syrup urine disease: mechanisms and management. Appl Clin Genet. 2017;10:57\u201366.","journal-title":"Appl Clin Genet"},{"key":"4043_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2022.105360","volume":"157","author":"AU Amaral","year":"2022","unstructured":"Amaral AU, Wajner M. Pathophysiology of maple syrup urine disease: focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain \u03b1-keto acids. Neurochem Int. 2022;157:105360.","journal-title":"Neurochem Int"},{"key":"4043_CR11","first-page":"631","volume":"41","author":"G Scaini","year":"2018","unstructured":"Scaini G, Tonon T, Moura de Souza CF, et al. Evaluation of plasma biomarkers of inflammation in patients with maple syrup urine disease. JIMD. 2018;41:631\u201340.","journal-title":"JIMD."},{"key":"4043_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ijdevneu.2019.07.007","volume":"78","author":"LB Wessler","year":"2019","unstructured":"Wessler LB, Ramos De Miranda, Pasquali B, et al. Administration of branched-chain amino acids increases the susceptibility to lipopolysaccharide-induced inflammation in young Wistar rats. Int J Dev Neurosci. 2019;78:210\u20134.","journal-title":"Int J Dev Neurosci"},{"issue":"5","key":"4043_CR13","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s11011-023-01193-8","volume":"38","author":"F Rabelo","year":"2023","unstructured":"Rabelo F, Lemos IDS, Dal To\u00e9 C, et al. Acute effects of intracerebroventricular administration of \u03b1-ketoisocaproic acid in young rats on inflammatory parameters. Metab Brain Dis. 2023;38(5):1573\u20139.","journal-title":"Metab Brain Dis"},{"issue":"6","key":"4043_CR14","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1017\/cjn.2019.253","volume":"46","author":"S Culleton","year":"2019","unstructured":"Culleton S, Siddiqui A. Maple syrup urine disease decompensation presenting as papilloedema. Can J Neurol Sci. 2019;46(6):780\u20131.","journal-title":"Can J Neurol Sci"},{"issue":"3","key":"4043_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1468-1331.2008.02425.x","volume":"16","author":"R Sutter","year":"2009","unstructured":"Sutter R, Killer HE, Bilz S, et al. Cerebral oedema and intracranial hypertension in an adult with maple syrup urine disease. Eur J Neurol. 2009;16(3):45\u20136.","journal-title":"Eur J Neurol."},{"issue":"5","key":"4043_CR16","doi-asserted-by":"publisher","first-page":"398","DOI":"10.5152\/dir.2017.16466","volume":"23","author":"A Cheng","year":"2017","unstructured":"Cheng A, Han L, Feng Y, Li H, et al. MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases. Diagn Interv Radiol. 2017;23(5):398\u2013402.","journal-title":"Diagn Interv Radiol"},{"key":"4043_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00247-003-1058-7","volume":"34","author":"JS Ha","year":"2004","unstructured":"Ha JS, Kim TK, Eun BL, et al. Maple syrup urine disease encephalopathy: a follow-up study in the acute stage using diffusion-weighted MRI. Pediatr Radiol. 2004;34:163\u20136.","journal-title":"Pediatr Radiol"},{"issue":"6","key":"4043_CR18","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10545-017-0083-x","volume":"40","author":"MT Abi-Ward\u00e9","year":"2017","unstructured":"Abi-Ward\u00e9 MT, Arnoux JB, Servais A, et al. Long-term metabolic follow-up and clinical outcome of 35 patients with maple syrup urine disease. J Inherit Metab Dis. 2017;40(6):783\u201392.","journal-title":"J Inherit Metab Dis"},{"key":"4043_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-9-73","volume":"9","author":"KR Vogel","year":"2014","unstructured":"Vogel KR, Arning E, Wasek BL, et al. Brain-blood amino acid correlates following protein restriction in murine maple syrup urine disease. Orphanet J Rare Dis. 2014;9:73.","journal-title":"Orphanet J Rare Dis"},{"key":"4043_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.pediatrneurol.2022.07.013","volume":"135","author":"K Sen","year":"2022","unstructured":"Sen K, Gropman A, Harrar D. In-hospital mortality from cerebral edema in MSUD during newborn screening era: what are we missing and what more can we do? Pediatr Neurol. 2022;135:61\u20132.","journal-title":"Pediatr Neurol"},{"key":"4043_CR21","first-page":"103","volume":"3","author":"KA Myers","year":"2012","unstructured":"Myers KA, Reeves M, Wei XC, et al. Cerebral edema in maple syrup urine disease despite newborn screening diagnosis and early initiation of treatment. JIMD Rep. 2012;3:103\u20136.","journal-title":"JIMD Rep"},{"issue":"6","key":"4043_CR22","first-page":"1219","volume":"11","author":"J Brismar","year":"1990","unstructured":"Brismar J, Aqeel A, Brismar G, et al. Maple syrup urine disease: findings on CT and MR scans of the brain in 10 infants. AJNR. 1990;11(6):1219\u201328.","journal-title":"AJNR."},{"key":"4043_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ajem.2022.02.053","volume":"55","author":"RA Sulaiman","year":"2022","unstructured":"Sulaiman RA, Alali A, Hosaini S, et al. Emergency management of critically ill adult patients with inherited metabolic disorders. Am J Emerg Med. 2022;55:138\u201342.","journal-title":"Am J Emerg Med"},{"key":"4043_CR24","first-page":"32","volume":"18","author":"T Hashimoto","year":"2022","unstructured":"Hashimoto T, Whitehead MT, MacLeod E, et al. Maple syrup urine disease decompensation is misdiagnosed as a psychotic event. Mol Genet Metab Rep. 2022;18:32.","journal-title":"Mol Genet Metab Rep"},{"issue":"1","key":"4043_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13023-025-03533-6","volume":"20","author":"N Rostampour","year":"2025","unstructured":"Rostampour N, Dalili S, Moravej H, et al. Comprehensive Iranian guidelines for the diagnosis and management of maple syrup urine disease: an evidence- and consensus- based approach. Orphanet J Rare Dis. 2025;20(1):8.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"4043_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00467-001-0801-2","volume":"17","author":"DP Puliyanda","year":"2002","unstructured":"Puliyanda DP, Harmon WE, Peterschmitt MJ, et al. Utility of hemodialysis in maple syrup urine disease. Pediatr Nephrol. 2002;17(4):239\u201342.","journal-title":"Pediatr Nephrol"},{"key":"4043_CR27","first-page":"46","volume":"4","author":"PS Atwal","year":"2015","unstructured":"Atwal PS, Macmurdo C, Grimm PC. Haemodialysis is an effective treatment in acute metabolic decompensation of maple syrup urine disease. Mol Genet Metab Rep. 2015;4:46\u20138.","journal-title":"Mol Genet Metab Rep"},{"issue":"3","key":"4043_CR28","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/1744-9987.13816","volume":"26","author":"I Deger","year":"2022","unstructured":"Deger I, \u00c7elik M, Ta\u015f I, et al. Continuous veno-venous hemodiafiltration in neonates with maple syrup urine disease. Ther Apher Dial. 2022;26(3):658\u201366.","journal-title":"Ther Apher Dial"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04043-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-04043-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04043-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:57:21Z","timestamp":1763549841000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-04043-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4043"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-04043-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Research Advisory Council of the King Faisal Specialist Hospital and Research Center approved this research project (RAC # 2221255).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors declare no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"594"}}